Clinical insights on the use of highly sensitive cardiac troponin assays

Clinica Chimica Acta

Volumn 284, Issue 2, 1999, Pages 175-185

  Missov, Emil D ^a   De Marco, Teresa ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Biochemical markers; Cardiac troponin I; Cardiac troponin T; Congestive heart failure

Indexed keywords

BIOCHEMICAL MARKER; CREATINE KINASE MB; TROPONIN; TROPONIN I; TROPONIN T;

APOPTOSIS; CELL DEATH; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; FOLLOW UP; HEART MUSCLE INJURY; HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

BIOLOGICAL MARKERS; HEART FAILURE, CONGESTIVE; HUMANS; MYOCARDIUM; SENSITIVITY AND SPECIFICITY; TROPONIN I; TROPONIN T;

EID: 0032993854     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(99)00079-0     Document Type: Conference Paper

References (31)

1. Dean KJ. Biochemistry and molecular biology of troponins I and T. In: Wu AHB, editor. Cardiac Markers. Totowa, NJ: Humana Press Inc, 1998, p. 193-204.
2. Larue C., Calzolari C., Bertinchant J.-P., Leclercq F., Grolleau R., Pau B. Cardiac-specific immunoenzymometric assay of troponin I in the early phase of acute myocardial infarction. Clin Chem. 39:1993;972-979.
3. Katus H., Remppis A., Neumann F.J., et al. Diagnostic efficiency of troponin T measurements in acute myocardial infarction. Circulation. 83:1991;902-912.
4. Guest T.M., Ramanathan A.V., Tuteur P.G., Schechtman K.B., Ladenson J.H., Jaffe A.S. Myocardial injury in critically ill patients: a frequently unrecognized complication. J Am Med Assoc. 273:1995;1945-1949.
5. Adams J.E., Bodor G.S., Davila-Roman V.G., et al. Cardiac troponin I: a marker with high specificity for cardiac injury. Circulation. 88:1993;101-106.
6. Hamm C.W., Ravkilde J., Gerhardt, et al. The prognostic value of serum troponin T in unstable angina. New Engl J Med. 327:1992;146-150.
7. Antman E.M., Tanasievic M.J., Thompson B., et al. Cardiac troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. New Engl J Med. 335:1996;1342-1349.
8. Ohman E.M., Armstrong P.W., Christenson R.H., et al. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. N Engl J Med. 335:1996;1333-1341.
9. Christenson R.H., Duh S.H., Newby L.K., et al. Cardiac troponin T and cardiac troponin I: relative values in short-term risk stratification of patients with acute coronary syndromes. Clin Chem. 44:1998;494-501.
10. Adams J.E., Abendschein D.R., Jaffe A.S. Biochemical markers of myocardial injury: is MB creatine kinase the choice for the 1990s? Circulation. 88:1993;750-763.
11. Ertl G., Kochsiek K. Development, early treatment, and prevention of heart failure. Circulation. 87:(Suppl IV):1993;1-3.
12. Packer M. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol. 20:1992;248-254.
13. Mancia G. Neurohumoral activation in congestive heart failure. Am Heart J. 120:1990;1532-1537.
14. Beltrami C.A., Finato N., Rocco M., et al. Structural basis of end-stage failure in ischemic cardiomyopathy in humans. Circulation. 89:1994;151-163.
15. Schaper J.S., Froede R., Hein S., et al. Impairment of the myocardial ultrastructure of the cytoskeleton in dilated cardiomyopathy. Circulation. 83:1991;504-514.
16. Bing O.H. Hypothesis: apoptosis may be a mechanism for the transition to heart failure with chronic pressure overload. J Mol Cell Cardiol. 26:1994;943-948.
17. Katz A.M. Cell death in the failing heart: role of an unnatural growth response to overload. Clin Cardiol. 18:1995;36-44.
18. Majno G., Joris I. Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol. 146:1995;3-15.
19. Gao W.D., Atar D., Perez N.G., Murphy A.M., Marban E. Role of troponin I proteolysis in the pathogenesis of stunned myocardium. Circ Res. 80:1997;393-399.
20. Larue C., Defacque-Lacquement H., Calzolari C., LeNguyen D., Pau B. New monoclonal antibodies as probes for human cardiac troponin I: epitopic analysis with synthetic peptides. Mol Immunol. 29:1992;271-278.
21. Rama D., Calzolari C., Granier C., Pau B. Epitope localization of monoclonal antibodies for human troponin I immunoenzymometric assay. Hybridoma. 16:1997;153-157.
22. Müller-Bardorff M., Hallermayer K., Schröder A., et al. Improved troponin T ELISA specific for cardiac troponin T isoform: assay development and analytical and clinical validation. Clin Chem. 43:1997;458-466.
23. Missov E., Calzolari C. Elevated cardiac troponin I in some patients with severe congestive heart failure. J Mol Cell Cardiol. 27:1995;A405. (Abstract).
24. Missov E., Calzolari C., Pau B. Circulating cardiac troponin I in severe congestive heart failure. Circulation. 96:1997;2953-2958.
25. Missov E., Mair J. A novel biochemical approach to congestive heart failure in humans: cardiac troponin T. Circulation. 98:1998;I24. (Abstract).
26. Missov E, Mair J. A novel biochemical approach to congestive heart failure: cardiac troponin T. Am Heart J 1999:in press.
27. Sutton G.C. Epidemiologic aspects of heart failure. Am Heart J. 120:1990;1538-1540.
28. Kannel W.B., Belanger A.J. Epidemiology of heart failure. Am Heart J. 121:1991;951-957.
29. Ho K.K., Anderson K.M., Kannel W.B., Grossman W., Levy D. Survival after the onset of congestive heart failure in the Framingham Heart Study subjects. Circulation. 88:1993;107-115.
30. Setsuta K., Ohtsuka T., Ogawa T. et al. Prognostic value of a second generation cardiac troponin T in patients with chronic heart failure. J Am Coll Cardiol. 31:1998;249A. (Abstract).
31. Wu A., Feng Y.J., Moore R., et al. Characterization of cardiac troponin subunit release into serum after acute myocardial infarction and comparison of assays for troponin T and I. Clin Chem. 44:1998;1198-1208.